Parth Mehrotra - 30 Apr 2025 Form 4 Insider Report for Privia Health Group, Inc. (PRVA)

Role
Chief Executive Officer, Director
Signature
/s/ Anita Beth Adams, as attorney-in-fact
Issuer symbol
PRVA
Transactions as of
30 Apr 2025
Net transactions value
-$753,067
Form type
4
Filing time
02 May 2025, 16:58:27 UTC
Previous filing
14 Mar 2025
Next filing
14 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mehrotra Parth Chief Executive Officer, Director PRIVIA HEALTH GROUP, INC., 950 N. GLEBE RD., SUITE 700, ARLINGTON /s/ Anita Beth Adams, as attorney-in-fact 02 May 2025 0001858398

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRVA Common Stock, $0.01 par value per share Sale $352,283 -15,100 -3.2% $23.33 454,281 30 Apr 2025 Direct F1
transaction PRVA Common Stock, $0.01 par value per share Sale $400,784 -17,365 -3.8% $23.08 436,916 01 May 2025 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.
F2 This transaction occurred pursuant to a 10b5-1 trading plan previously adopted by the reporting person.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.87 to $23.43 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.